<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03173586</url>
  </required_header>
  <id_info>
    <org_study_id>1999-P-011114</org_study_id>
    <nct_id>NCT03173586</nct_id>
  </id_info>
  <brief_title>Sugar Sweetened Beverage Intake and Biomarkers of Cardiometabolic Risk in US Women</brief_title>
  <official_title>Association Between Sugar Sweetened Beverage Intake and Biomarkers of Cardiometabolic Risk in US Women</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Harvard School of Public Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Harvard School of Public Health</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is a secondary analysis of data collected in the Nurses' Health Study (NHS) that
      will evaluat the association between intake of sugar sweetened beverages (SSB), juice and
      artificially sweetened beverages in relation to biomarkers of hepatic function, lipid
      metabolism, inflammation and glycemic control.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators will analyze cross-sectional data from 8,492 participants in the Nurses'
      Health Study who were free of diabetes and cardiovascular disease to evaluate the association
      between intake of sugar sweetened beverages (SSB), juice and artificially sweetened beverages
      (ASB) and biomarkers of hepatic function, lipid metabolism, inflammation and glycemic
      control. Biomarkers were measured from blood samples that were collected in 2 cycles,
      approximately 10 years apart.

      Specifically, multivariate linear regression will be used to assess the associations of SSB,
      ASB, and fruit juice intake with concentrations of fetuin-A, alanine transaminase,
      gamma-glutamyl transferase, triglycerides, high-density lipoprotein cholesterol (HDL-C),
      low-density lipoprotein cholesterol (LDL-C), total cholesterol, C-reactive protein (CRP),
      intracellular adhesion molecule 1 (ICAM-1), vascular cell adhesion protein 1 (VCAM-1),
      adiponectin, insulin, and hemoglobin A1c as well as total cholesterol/HDL-C ratio.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 16, 1999</start_date>
  <completion_date type="Actual">March 31, 2009</completion_date>
  <primary_completion_date type="Actual">March 31, 2009</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Fetuin-A</measure>
    <time_frame>Blood collection cycle 1 (1989-1990)</time_frame>
    <description>Biomarkers of liver function</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Fetuin-A</measure>
    <time_frame>Blood collection cyle 2 (2000-2001)</time_frame>
    <description>Biomarkers of liver function</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Alanine transaminase</measure>
    <time_frame>Blood collection cycle 1 (1989-1990)</time_frame>
    <description>Biomarkers of liver function</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Alanine transaminase</measure>
    <time_frame>Blood collection cyle 2 (2000-2001)</time_frame>
    <description>Biomarkers of liver function</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Gamma-glutamyl transferase</measure>
    <time_frame>Blood collection cycle 1 (1989-1990)</time_frame>
    <description>Biomarkers of liver function</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Gamma-glutamyl transferase</measure>
    <time_frame>Blood collection cyle 2 (2000-2001)</time_frame>
    <description>Biomarkers of liver function</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Triglycerides</measure>
    <time_frame>Blood collection cycle 1 (1989-1990)</time_frame>
    <description>Biomarkers of lipid metabolism</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Triglycerides</measure>
    <time_frame>Blood collection cycle 2 (2000-2001)</time_frame>
    <description>Biomarkers of lipid metabolism</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>High-density lipoprotein cholesterol (HDL-C)</measure>
    <time_frame>Blood collection cycle 1 (1989-1990)</time_frame>
    <description>Biomarkers of lipid metabolism</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>High-density lipoprotein cholesterol (HDL-C)</measure>
    <time_frame>Blood collection cycle 2 (2000-2001)</time_frame>
    <description>Biomarkers of lipid metabolism</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Low-density lipoprotein cholesterol (LDL-C)</measure>
    <time_frame>Blood collection cycle 1 (1989-1990)</time_frame>
    <description>Biomarkers of lipid metabolism</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Low-density lipoprotein cholesterol (LDL-C)</measure>
    <time_frame>Blood collection cycle 2 (2000-2001)</time_frame>
    <description>Biomarkers of lipid metabolism</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total cholesterol</measure>
    <time_frame>Blood collection cycle 1 (1989-1990)</time_frame>
    <description>Biomarkers of lipid metabolism</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total cholesterol</measure>
    <time_frame>Blood collection cycle 2 (2000-2001)</time_frame>
    <description>Biomarkers of lipid metabolism</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total cholesterol/HDL-C ratio</measure>
    <time_frame>Blood collection cycle 1 (1989-1990)</time_frame>
    <description>Biomarkers of lipid metabolism</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total cholesterol/HDL-C ratio</measure>
    <time_frame>Blood collection cycle 2 (2000-2001)</time_frame>
    <description>Biomarkers of lipid metabolism</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>C-reactive protein (CRP)</measure>
    <time_frame>Blood collection cycle 1 (1989-1990)</time_frame>
    <description>Biomarkers of inflammation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>C-reactive protein (CRP)</measure>
    <time_frame>Blood collection cycle 2 (2000-2001)</time_frame>
    <description>Biomarkers of inflammation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intracellular adhesion molecule 1 (ICAM-1)</measure>
    <time_frame>Blood collection cycle 1 (1989-1990)</time_frame>
    <description>Biomarkers of inflammation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intracellular adhesion molecule 1 (ICAM-1)</measure>
    <time_frame>Blood collection cycle 2 (2000-2001)</time_frame>
    <description>Biomarkers of inflammation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vascular cell adhesion protein 1 (VCAM-1)</measure>
    <time_frame>Blood collection cycle 1 (1989-1990)</time_frame>
    <description>Biomarkers of inflammation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vascular cell adhesion protein 1 (VCAM-1)</measure>
    <time_frame>Blood collection cycle 2 (2000-2001)</time_frame>
    <description>Biomarkers of inflammation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Insulin</measure>
    <time_frame>Blood collection cycle 1 (1989-1990)</time_frame>
    <description>Biomarkers of glucose metabolism</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Insulin</measure>
    <time_frame>Blood collection cycle 2 (2000-2001)</time_frame>
    <description>Biomarkers of glucose metabolism</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hemoglobin A1c</measure>
    <time_frame>Blood collection cycle 1 (1989-1990)</time_frame>
    <description>Biomarkers of glucose metabolism</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hemoglobin A1c</measure>
    <time_frame>Blood collection cycle 2 (2000-2001)</time_frame>
    <description>Biomarkers of glucose metabolism</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">33000</enrollment>
  <condition>Biomarkers</condition>
  <arm_group>
    <arm_group_label>NHS</arm_group_label>
    <description>Least-squares mean (95% CI) concentrations of biomarkers by frequency of sugar sweetened beverage (SSB) intake among participants free of diabetes and cardiovascular disease in the NHS.
Least-squares mean (95% CI) concentrations of biomarkers by frequency of artificially sweetened beverage (ASB) intake among participants free of diabetes and cardiovascular disease in the NHS.
Least-squares mean (95% CI) concentrations of biomarkers by frequency of fruit juice intake among participants free of diabetes and cardiovascular disease in the NHS.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Sugar sweetened beverage (SSB)</intervention_name>
    <description>This is an observational study examining sugar sweetened beverage intake in relation to biomarkers in the NHS.</description>
    <arm_group_label>NHS</arm_group_label>
    <other_name>Artificially sweetened beverage (ASB), juice</other_name>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      The major goal of the project was to analyze blood samples collected from 33,000 women
      participating in the Nurses' Health Study. The aim of the original grant was to asses plasma
      sex hormone levels in relation to risk of breast cancer; plasma beta-carotene, Vitamin E and
      omega-3 fatty acids and risk of breast and colon cancer; specific lipoprotein fractions,
      apoproteins and fatty acids and risk of CVD.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        The Nurses' Health Study (NHS) is a prospective cohort study of 121,700 female registered
        nurses aged 30-55 years at baseline in 1976. Mailed questionnaires were administered
        biennially to collect data on medical, dietary, and lifestyle factors, with a follow-up
        rate exceeding 90% for each 2-year cycle. Blood samples were collected from 32,826
        participants between 1989 and 1990 (biospecimen collection cycle 1) and 18,717 participants
        between 2000 and 2001 (biospecimen collection cycle 2). Participants who provided a blood
        specimen were generally similar to those who did not in terms of diet and lifestyle
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        For the current study, we included participants who provided a blood sample and were
        previously selected as controls for nested case-control analyses of type 2 diabetes,
        coronary heart disease, stroke, colon cancer, colon polyps, pancreatic cancer, and breast
        cancer in the Nurse's Health Study.

        Exclusion Criteria:

        Participants with self-reported prevalent diabetes or cardiovascular disease (CVD) at blood
        draw were excluded. After exclusions, a total of 8,492 individuals (6,961 from cycle 1 and
        1,531 from cycle 2) with valid beverage intake data were included in the current analysis.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Our analysis was based on a cohort of female registered nurses.</gender_description>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vasanti Malik, ScD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Research Scientist</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Harvard T.H. Chan School of Public Health</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Malik VS, Popkin BM, Bray GA, Després JP, Willett WC, Hu FB. Sugar-sweetened beverages and risk of metabolic syndrome and type 2 diabetes: a meta-analysis. Diabetes Care. 2010 Nov;33(11):2477-83. doi: 10.2337/dc10-1079. Epub 2010 Aug 6. Review.</citation>
    <PMID>20693348</PMID>
  </reference>
  <reference>
    <citation>Xi B, Huang Y, Reilly KH, Li S, Zheng R, Barrio-Lopez MT, Martinez-Gonzalez MA, Zhou D. Sugar-sweetened beverages and risk of hypertension and CVD: a dose-response meta-analysis. Br J Nutr. 2015 Mar 14;113(5):709-17. doi: 10.1017/S0007114514004383. Epub 2015 Mar 4. Review.</citation>
    <PMID>25735740</PMID>
  </reference>
  <reference>
    <citation>de Koning L, Malik VS, Kellogg MD, Rimm EB, Willett WC, Hu FB. Sweetened beverage consumption, incident coronary heart disease, and biomarkers of risk in men. Circulation. 2012 Apr 10;125(14):1735-41, S1. doi: 10.1161/CIRCULATIONAHA.111.067017. Epub 2012 Mar 12.</citation>
    <PMID>22412070</PMID>
  </reference>
  <reference>
    <citation>Bazzano LA, Li TY, Joshipura KJ, Hu FB. Intake of fruit, vegetables, and fruit juices and risk of diabetes in women. Diabetes Care. 2008 Jul;31(7):1311-7. doi: 10.2337/dc08-0080. Epub 2008 Apr 4.</citation>
    <PMID>18390796</PMID>
  </reference>
  <reference>
    <citation>Schulze MB, Manson JE, Ludwig DS, Colditz GA, Stampfer MJ, Willett WC, Hu FB. Sugar-sweetened beverages, weight gain, and incidence of type 2 diabetes in young and middle-aged women. JAMA. 2004 Aug 25;292(8):927-34.</citation>
    <PMID>15328324</PMID>
  </reference>
  <reference>
    <citation>Nettleton JA, Lutsey PL, Wang Y, Lima JA, Michos ED, Jacobs DR Jr. Diet soda intake and risk of incident metabolic syndrome and type 2 diabetes in the Multi-Ethnic Study of Atherosclerosis (MESA). Diabetes Care. 2009 Apr;32(4):688-94. doi: 10.2337/dc08-1799. Epub 2009 Jan 16.</citation>
    <PMID>19151203</PMID>
  </reference>
  <reference>
    <citation>de Koning L, Malik VS, Rimm EB, Willett WC, Hu FB. Sugar-sweetened and artificially sweetened beverage consumption and risk of type 2 diabetes in men. Am J Clin Nutr. 2011 Jun;93(6):1321-7. doi: 10.3945/ajcn.110.007922. Epub 2011 Mar 23.</citation>
    <PMID>21430119</PMID>
  </reference>
  <reference>
    <citation>Willett WC, Sampson L, Stampfer MJ, Rosner B, Bain C, Witschi J, Hennekens CH, Speizer FE. Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol. 1985 Jul;122(1):51-65.</citation>
    <PMID>4014201</PMID>
  </reference>
  <reference>
    <citation>Salvini S, Hunter DJ, Sampson L, Stampfer MJ, Colditz GA, Rosner B, Willett WC. Food-based validation of a dietary questionnaire: the effects of week-to-week variation in food consumption. Int J Epidemiol. 1989 Dec;18(4):858-67.</citation>
    <PMID>2621022</PMID>
  </reference>
  <reference>
    <citation>Ley SH, Sun Q, Jimenez MC, Rexrode KM, Manson JE, Jensen MK, Rimm EB, Hu FB. Association between alcohol consumption and plasma fetuin-A and its contribution to incident type 2 diabetes in women. Diabetologia. 2014 Jan;57(1):93-101. doi: 10.1007/s00125-013-3077-8. Epub 2013 Oct 9.</citation>
    <PMID>24105100</PMID>
  </reference>
  <reference>
    <citation>Nimptsch K, Brand-Miller JC, Franz M, Sampson L, Willett WC, Giovannucci E. Dietary insulin index and insulin load in relation to biomarkers of glycemic control, plasma lipids, and inflammation markers. Am J Clin Nutr. 2011 Jul;94(1):182-90. doi: 10.3945/ajcn.110.009555. Epub 2011 May 4.</citation>
    <PMID>21543531</PMID>
  </reference>
  <reference>
    <citation>Sun Q, Cornelis MC, Manson JE, Hu FB. Plasma levels of fetuin-A and hepatic enzymes and risk of type 2 diabetes in women in the U.S. Diabetes. 2013 Jan;62(1):49-55. doi: 10.2337/db12-0372. Epub 2012 Aug 24.</citation>
    <PMID>22923470</PMID>
  </reference>
  <reference>
    <citation>Malik VS, Pan A, Willett WC, Hu FB. Sugar-sweetened beverages and weight gain in children and adults: a systematic review and meta-analysis. Am J Clin Nutr. 2013 Oct;98(4):1084-102. doi: 10.3945/ajcn.113.058362. Epub 2013 Aug 21. Review.</citation>
    <PMID>23966427</PMID>
  </reference>
  <reference>
    <citation>Liu S, Manson JE, Buring JE, Stampfer MJ, Willett WC, Ridker PM. Relation between a diet with a high glycemic load and plasma concentrations of high-sensitivity C-reactive protein in middle-aged women. Am J Clin Nutr. 2002 Mar;75(3):492-8.</citation>
    <PMID>11864854</PMID>
  </reference>
  <reference>
    <citation>Fung TT, Malik V, Rexrode KM, Manson JE, Willett WC, Hu FB. Sweetened beverage consumption and risk of coronary heart disease in women. Am J Clin Nutr. 2009 Apr;89(4):1037-42. doi: 10.3945/ajcn.2008.27140. Epub 2009 Feb 11.</citation>
    <PMID>19211821</PMID>
  </reference>
  <reference>
    <citation>Pan A, Malik VS, Schulze MB, Manson JE, Willett WC, Hu FB. Plain-water intake and risk of type 2 diabetes in young and middle-aged women. Am J Clin Nutr. 2012 Jun;95(6):1454-60. doi: 10.3945/ajcn.111.032698. Epub 2012 May 2.</citation>
    <PMID>22552035</PMID>
  </reference>
  <reference>
    <citation>Pan A, Malik VS, Hao T, Willett WC, Mozaffarian D, Hu FB. Changes in water and beverage intake and long-term weight changes: results from three prospective cohort studies. Int J Obes (Lond). 2013 Oct;37(10):1378-85. doi: 10.1038/ijo.2012.225. Epub 2013 Jan 15.</citation>
    <PMID>23318721</PMID>
  </reference>
  <reference>
    <citation>Malik VS, Chiuve SE, Campos H, Rimm EB, Mozaffarian D, Hu FB, Sun Q. Circulating Very-Long-Chain Saturated Fatty Acids and Incident Coronary Heart Disease in US Men and Women. Circulation. 2015 Jul 28;132(4):260-8. doi: 10.1161/CIRCULATIONAHA.114.014911. Epub 2015 Jun 5.</citation>
    <PMID>26048094</PMID>
  </reference>
  <reference>
    <citation>AlEssa HB, Ley SH, Rosner B, Malik VS, Willett WC, Campos H, Hu FB. High Fiber and Low Starch Intakes Are Associated with Circulating Intermediate Biomarkers of Type 2 Diabetes among Women. J Nutr. 2016 Feb;146(2):306-17. doi: 10.3945/jn.115.219915. Epub 2016 Jan 13.</citation>
    <PMID>26764316</PMID>
  </reference>
  <reference>
    <citation>Yu Z, Malik VS, Keum N, Hu FB, Giovannucci EL, Stampfer MJ, Willett WC, Fuchs CS, Bao Y. Associations between nut consumption and inflammatory biomarkers. Am J Clin Nutr. 2016 Sep;104(3):722-8. doi: 10.3945/ajcn.116.134205. Epub 2016 Jul 27.</citation>
    <PMID>27465378</PMID>
  </reference>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 26, 2017</study_first_submitted>
  <study_first_submitted_qc>May 30, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 2, 2017</study_first_posted>
  <last_update_submitted>May 30, 2017</last_update_submitted>
  <last_update_submitted_qc>May 30, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 2, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Harvard School of Public Health</investigator_affiliation>
    <investigator_full_name>Vasanti Malik</investigator_full_name>
    <investigator_title>Research Scientist</investigator_title>
  </responsible_party>
  <keyword>Sugar sweetened beverage, biomarker</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Data are de-identified</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

